Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02823626 · ClinicalTrials.gov registry record
High-dose Aldosterone Antagonist for Acute Decompensated Heart Failure
A clinical trial, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- 48
- Enrollment target
NCT02823626: Completed study, sponsored by The University of Texas Health Science Center at San Antonio.
NCT02823626 is a clinical trial that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02823626 has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
Primary Aims 1. Evaluate the safety of high-dose spironolactone in combination of patiromer in acute decompensated heart failure patients. 2. Evaluate the efficacy of high-dose spironolactone in combination of patiromer in causing volume loss and symptom relief in patients with ADHF treated with high-dose spironolactone. Secondary Aims 1: Evaluate the effect of high-dose spironolactone on urinary sodium excretion and renal function.
Primary Outcome
Improved swelling and shortness of breath suggestive of volume loss
Interventions
- DRUG Spironolactone and patiromer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-04 |
What the finished NCT02823626 record still lists
NCT02823626 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Spironolactone and patiromer is the first listed.
NCT02823626 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02823626 about?
NCT02823626 is a clinical study titled "High-dose Aldosterone Antagonist for Acute Decompensated Heart Failure". Primary Aims 1. Evaluate the safety of high-dose spironolactone in combination of patiromer in acute decompensated heart failure patients. 2. Evaluate the efficacy of high-dose spironolactone in combination of patiromer in causing volume loss and symptom relief in patients with ADHF treated with hi...
What is the current status of trial NCT02823626?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2016-09. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02823626?
The interventions under investigation include: Spironolactone and patiromer (DRUG).
Who is sponsoring clinical trial NCT02823626?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia